Manning & Napier Group's CRL Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 14 shares of Charles River Laboratories International, Inc. (CRL) worth $3,158, representing 0.00% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Manning & Napier Group has maintained a strategic position in CRL, demonstrating sustained confidence in this investment. Largest reduction occurred in Q2 2026, reducing 13,945 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Charles River Laboratories International (CRL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Charles River Laboratories International (CRL) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +14 | New Buy | 14 | $225.57 |
| Q1 2023 | -13,959 | Sold Out | 13,959 | $217.90 |
| Q4 2022 | +13,959 | New Buy | 13,959 | $217.90 |
Manning & Napier Group's Charles River Laboratories International Investment FAQs
Manning & Napier Group first purchased Charles River Laboratories International, Inc. (CRL) in Q4 2022, acquiring 13,959 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Charles River Laboratories International, Inc. (CRL) for 15 quarters since Q4 2022.
Manning & Napier Group's largest addition to Charles River Laboratories International, Inc. (CRL) was in Q4 2022, adding 13,959 shares worth $3.04 M.
According to the latest 13F filing for Q2 2026, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 14 shares of Charles River Laboratories International, Inc. (CRL), valued at approximately $3,158.
As of the Q2 2026 filing, Charles River Laboratories International, Inc. (CRL) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Charles River Laboratories International, Inc. (CRL) was 13,959 shares, as reported at the end of Q4 2022.